99mTc MIBI in neurofibromatosis imaging diagnosis: case report.
99mTc MIBI has been shown to accumulate in different cancer cells types, in vitro and malignant tumours in vivo, making evidence of the scintigraphic diagnostic of them. We report two cases of neurofibromatosis type I, which has realised high levels of 99mTc MIBI uptake, primary to all chemo- or radiotherapy. Only certain zones of tumorous localisation have been seen, but a relation with the lesion histology was not really established. In conclusion, 99mTc MIBI scintigraphy may be usefull in the investigation of type I neurofibromatosis.
Stefănescu
C
C
Disciplina de Biofizică şi Medicina Nucleară, Facultatea de Medicină, U.M.F. Gr. T. Popa, Iaşi.
Meignan
M
M
Volkenstein
P
P
Rusu
V
V
D000293:Adolescent; D000328:Adult; D001132:Arm; D001706:Biopsy; D005153:Facial Neoplasms / Q000000981:diagnostic imaging*; D006801:Humans; D008297:Male; D009456:Neurofibromatosis 1 / Q000000981:diagnostic imaging*; D018319:Neurofibrosarcoma / Q000000981:diagnostic imaging / Q000473:pathology; D011877:Radionuclide Imaging; D012878:Skin Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D017256:Technetium Tc 99m Sestamibi; D013848:Thigh
D017256:Technetium Tc 99m Sestamibi